Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.
D000284:Administration, Oral; D000328:Adult; D015992:Body Mass Index; D001835:Body Weight / Q000502:physiology*; D004311:Double-Blind Method; D005260:Female; D006728:Hormones / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000502:physiology*; D008687:Metformin / Q000627:therapeutic use*; D009765:Obesity / Q000150:complications*; D010919:Placebos; D011085:Polycystic Ovary Syndrome / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D012016:Reference Values; D016896:Treatment Outcome
D006728:Hormones; D007004:Hypoglycemic Agents; D007328:Insulin; D010919:Placebos; D008687:Metformin